Insider trades

Krishnan Nandabalan, Director of BioXcel Therapeutics BTAIQ, has filed 0 purchases and 5 sales on the open market. The latest trade was on 23/04/06.

Krishnan Nandabalan

Director
First filing
23/01/06
Trades
11 trades
Buys / sales
0 / 5
12-month net buying
No record
Last trade
23/04/06

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan23/04/0623/04/1060,000 sh$17.32$1,039,200−100.0%
BTAIQ
Open-market sale23/01/04–23/01/0523/01/0660,000 sh4 trades$22.01avg.$1,320,875.99−100.0%